These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6378988)

  • 1. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial.
    Trimarco B; DeLuca N; Ricciardelli B; Volpe M; Veniero A; Cuocolo A; Cicala M
    J Clin Pharmacol; 1984; 24(5-6):218-27. PubMed ID: 6378988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
    Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G; Mazzola C; Boni S; Guffanti E; Meani A; Zanchetti A
    Eur J Clin Pharmacol; 1986; 30(6):637-40. PubMed ID: 3533561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP; Gordon NF
    Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Thulin T; Hedner T; Gustafsson S; Olsson SO
    J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of diltiazem in angina on effort: a multicenter trial.
    Hossack KF; Pool PE; Steele P; Crawford MH; DeMaria AN; Cohen LS; Ports TA
    Am J Cardiol; 1982 Feb; 49(3):567-72. PubMed ID: 7036710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of diltiazem and metoprolol in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Hedner T; Thulin T; Gustafsson S; Olsson SO
    Eur J Clin Pharmacol; 1990; 39(5):427-33. PubMed ID: 2076733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
    Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol.
    Yamakado T; Oonishi N; Kondo S; Noziri A; Nakano T; Takezawa H
    Am J Cardiol; 1983 Nov; 52(8):1023-7. PubMed ID: 6637817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
    Dahlöf C; Hedner T; Thulin T; Gustafsson S; Olsson SO
    Eur J Clin Pharmacol; 1991; 40(5):453-60. PubMed ID: 1884720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem for treatment of essential hypertension: a double-blind controlled study with reserpine.
    Ogawa K; Ban M; Ito T; Watanabe T; Kobayashi T; Yamazaki N; Suzuki Y
    Clin Ther; 1984; 6(6):844-53. PubMed ID: 6391669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone.
    Kieso HA; Gould BA; Mann S; Hornung RS; Altman DG; Raftery EB
    Br Med J (Clin Res Ed); 1983 Sep; 287(6394):717-20. PubMed ID: 6412795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized, crossover comparison of equivalent (by weight) oral doses of verapamil and diltiazem in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps MK; Gray J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S68-70. PubMed ID: 2475693
    [No Abstract]   [Full Text] [Related]  

  • 18. Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity.
    Szlachcic J; Hirsch AT; Tubau JF; Vollmer C; Henderson S; Massie BM
    Am J Cardiol; 1987 Feb; 59(5):393-9. PubMed ID: 3812308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
    Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):539-44. PubMed ID: 3323072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.